XML 70 R31.htm IDEA: XBRL DOCUMENT v3.22.2
Supplemental Information (Tables)
6 Months Ended
Jun. 30, 2022
Supplemental Information [Abstract]  
Schedule of Cash and Cash Equivalents Including Restricted Cash
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the balance sheets and the statements of cash flows at June 30, 2022, and December 31, 2021:
June 30, 2022December 31, 2021
AmerenAmeren
Missouri
Ameren
Illinois
AmerenAmeren
Missouri
Ameren
Illinois
“Cash and cash equivalents”$7 $ $ $$— $— 
Restricted cash included in “Other current assets”7 2 4 16 
Restricted cash included in “Other assets”142  142 127 — 127 
Restricted cash included in “Nuclear decommissioning trust fund”5 5  — 
Total cash, cash equivalents, and restricted cash$161 $7 $146 $155 $$133 
Schedule of Accounts, Notes, Loans and Financing Receivable
The following table provides a reconciliation of the beginning and ending amount of the allowance for doubtful accounts for the three and six months ended June 30, 2022 and 2021:
Three MonthsSix Months
2022202120222021
Ameren:
Beginning of period$28 $47 $29 $50 
Bad debt expense7 (3)11 
Net write-offs(5)(2)(10)(9)
End of period$30 $42 $30 $42 
Ameren Missouri:
Beginning of period$11 $15 $13 $16 
Bad debt expense2 3 
Net write-offs(1)(1)(4)(3)
End of period$12 $16 $12 $16 
Ameren Illinois:(a)
Beginning of period$17 $32 $16 $34 
Bad debt expense5 

(5)
(b)
8 (2)
(b)
Net write-offs(4)(1)(6)(6)
End of period$18 $26 $18 $26 
(a)Ameren Illinois has rate-adjustment mechanisms that allow it to recover the difference between its actual net bad debt write-offs under GAAP, including those associated with receivables purchased from alternative retail electric suppliers, and the amount of net bad debt write-offs included in its base rates.
(b)In the three and six months ended June 30, 2021, Ameren Illinois’ bad debt expense was reduced as a result of state funding received for customer bill assistance.
Schedule of Cash Flow, Supplemental Disclosures
The following table provides noncash financing and investing activity excluded from the statements of cash flows for the six months ended June 30, 2022 and 2021:
June 30, 2022June 30, 2021
AmerenAmeren
Missouri
Ameren
Illinois
AmerenAmeren
Missouri
Ameren
Illinois
Investing
Accrued capital expenditures$408 $204 $193 $434 $259 $174 
Net realized and unrealized gain/(loss) – nuclear decommissioning trust fund(211)(211) 85 85 — 
Financing
Issuance of common stock for stock-based compensation$31 $ $ $33 $— $— 
Issuance of common stock under the DRPlus8   — — — 
Asset Retirement Obligation Disclosure
The following table provides a reconciliation of the beginning and ending carrying amount of AROs for the six months ended June 30, 2022:
Ameren
Missouri
Ameren
Illinois
Ameren
Balance at December 31, 2021
$760 
(a)
$
(b)
$764 
(a)
Accretion15 
(c)
— 

15 
(c)
Change in estimates— 
Balance at June 30, 2022
$777 
(a)
$
(b)
$781 
(a)
(a)Balance included $7 million in “Other current liabilities” on the balance sheet as of both June 30, 2022, and December 31, 2021.
(b)Included in “Other deferred credits and liabilities” on the balance sheet.
(c)Accretion expense attributable to Ameren Missouri was recorded as a decrease to regulatory liabilities.
Schedule of excise taxes The following table presents the excise taxes recorded on a gross basis in “Operating Revenues – Electric,” “Operating Revenues – Natural gas” and “Operating Expenses – Taxes other than income taxes” on the statements of income for the three and six months ended June 30, 2022 and 2021:
Three MonthsSix Months
2022202120222021
Ameren Missouri$39 $35 $73 $66 
Ameren Illinois28 27 73 66 
Ameren$67 $62 $146 $132 
Schedule of Earnings Per Share, Basic and Diluted
The following table reconciles the basic weighted-average number of common shares outstanding to the diluted weighted-average number of common shares outstanding for the three and six months ended June 30, 2022 and 2021:
Three MonthsSix Months
2022202120222021
Weighted-average Common Shares Outstanding – Basic258.2 256.1 258.0 255.2 
Assumed settlement of performance share units and restricted stock units1.0 1.1 1.1 1.3 
Dilutive effect of forward sale agreements0.2 — 0.1 — 
Weighted-average Common Shares Outstanding – Diluted(a)
259.4 257.2 259.2 256.5 
(a)There was an immaterial number of anti-dilutive securities excluded from the earnings per diluted share calculations for the three and six months ended June 30, 2022. There were no anti-dilutive securities excluded from the earnings per diluted share calculations for the three and six months ended June 30, 2021.